Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 202931-88-2 | MDL No. : | MFCD10696346 |
Formula : | C4H5N3O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VFAQDMYUCHBIJL-UHFFFAOYSA-N |
M.W : | 111.10 | Pubchem ID : | 21187507 |
Synonyms : |
|
Num. heavy atoms : | 8 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.25 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 26.67 |
TPSA : | 47.78 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.35 cm/s |
Log Po/w (iLOGP) : | 0.73 |
Log Po/w (XLOGP3) : | -0.52 |
Log Po/w (WLOGP) : | -0.37 |
Log Po/w (MLOGP) : | -1.08 |
Log Po/w (SILICOS-IT) : | 0.11 |
Consensus Log Po/w : | -0.22 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.6 |
Solubility : | 28.1 mg/ml ; 0.253 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.01 |
Solubility : | 107.0 mg/ml ; 0.966 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.31 |
Solubility : | 54.2 mg/ml ; 0.488 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.56 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
30% | Stage #1: With n-butyllithium In tetrahydrofuran at -78 - -60℃; for 0.5 h; Stage #2: at 20℃; for 1 h; |
To a solution of 1-methyl-1 H-1 ,2,3-triazole (Preparation 32, 0.1 g, 1.2 mmol) in tetrahydrofuran (THF, 10 ml) at -780C was added dropwise 1.6 M n-butyl lithium (0.9 ml, 1.4 mmol), maintaining the temperature below -6O0C. The reaction was stirred at - 780C for 30 minutes, then dimethylformamide (0.14 ml, 1.8 mmol) was added. The reaction was warmed to room temperature and stirred for 1 hour. The reaction was quenched with water and extracted with ethyl acetate (3 x 10\\ ml). The combined organic extracts were washed with water (3 x 10 ml), dried over MgSO4 and concentrated in vacuo. The residue was purified by silica gel column chromatography, eluting with 95:5 to 100:0 dichloromethane:methanol, to afford the title compound as a yellow oil (0.04 g, 30percent yield).1HNMR (CDCI3): 4.10 (s, 3H)1 7.88 (s, 1 H), 9.55 (s, 1 H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
19% | With n-butyllithium In N,N-dimethyl-formamide | a 3-Methyl-3 H-1,2,3-triazole-4-carboxaldehyde To a stirred solution of 1-methyl-1 H-1,2,3-triazole (0.500 g, 6.02 mmol) in anhydrous THF (20 ml), cooled to -70° C. under nitrogen, was added dropwise a 1.6 M solution of butyl lithium in hexanes (4.23 ml, 6.77 mmol). The mixture was stirred at this temperature for 1 h, then anhydrous DMF (0.465 ml, 6.02 mmol) was added, and the mixture was allowed to warm to 0° C. over 30 min. Saturated aqueous NH4Cl (25 ml) was then added and the mixture was extracted with ethyl acetate. The organic layer was dried (Na2SO4) and evaporated in vacuo. The residue was purified by flash chromatography (silica gel, 40percent EtOAc/hexane) to give 0.128 g (19percent) of the title compound as a yellow oil: 1H NMR (360 MHz, d6-DMSO) δ4.27 (3 H, s), 8.45 (1 H, s), 10.01 (1 H, s); MS (ES+) m/e 144[M+MeOH+H]+, 111[M]+. |
[ 27258-33-9 ]
1-Methyl-1H-pyrazole-5-carbaldehyde
Similarity: 0.57
[ 499770-67-1 ]
1-Methyl-1H-benzo[d][1,2,3]triazole-5-carbaldehyde
Similarity: 0.54
[ 100305-93-9 ]
1-Isopropyl-1H-pyrazole-5-carbaldehyde
Similarity: 0.52
[ 25711-30-2 ]
1,5-Dimethyl-1H-pyrazole-4-carbaldehyde
Similarity: 0.52
[ 25016-09-5 ]
1,3-Dimethyl-1H-pyrazole-5-carbaldehyde
Similarity: 0.51
[ 716361-91-0 ]
1-Methyl-1H-1,2,3-triazole-5-carboxylic acid
Similarity: 0.81
[ 60166-43-0 ]
1,4-Dimethyl-1H-1,2,3-triazole
Similarity: 0.67
[ 885877-41-8 ]
4-Bromo-1,5-dimethyl-1H-1,2,3-triazole
Similarity: 0.65
[ 103755-58-4 ]
(1-Phenyl-1H-1,2,3-triazol-4-yl)methanol
Similarity: 0.62